Gateway Wealth Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$804K Sell
3,244
-16,410
-83% -$3.53M 0.05% 358
2026
Q1
$3.95M Buy
19,654
+12,495
+175% +$2.58M 0.15% 157
2025
Q4
$1.48M Buy
7,159
+692
+11% +$138K 0.16% 145
2025
Q3
$1.16M Buy
6,467
+340
+6% +$57.9K 0.16% 145
2025
Q2
$988K Buy
6,127
+111
+2% +$17.7K 0.19% 120
2025
Q1
$1.02M Buy
6,016
+658
+12% +$114K 0.23% 109
2024
Q4
$890K Buy
+5,358
New +$916K 0.23% 102
2024
Q3
Sell
-1,656
Closed -$255K 277
2024
Q2
$255K Buy
1,656
+61
+4% +$9.15K 0.08% 224
2024
Q1
$245K Sell
1,595
-217
-12% -$33.1K 0.09% 201
2023
Q4
$286K Buy
+1,812
New +$260K 0.12% 163

Other funds holding FBT

Gateway Wealth Partners's FBT Position: Q2 2026 in Review

Gateway Wealth Partners reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 83% in Q2 2026, selling an estimated $3.53M and leaving 3,244 shares worth $804K. The position accounts for 0.05% of the portfolio, ranked #358.

Gateway Wealth Partners first reported a position in FBT in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.95M in Q1 2026. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Gateway Wealth Partners held 3,244 shares of First Trust NYSE Arca Biotechnology Index Fund worth $804K as of Q2 2026.
  • Gateway Wealth Partners sold 16,410 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $3.53M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.05% of Gateway Wealth Partners's portfolio in Q2 2026, its #358 holding.
  • Gateway Wealth Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 10 quarters since.
  • Gateway Wealth Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.95M in Q1 2026.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Gateway Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.